On July 29, 2019, Taconic Biosciences announced the launch of the first commercially-available diet-induced NASH rodent model. These models will help accelerate clinical development of NASH treatments because they are readily-available off-the-shelf at are varying ages already expressing the symptoms of NASH. These models will save researchers months of planning and accelerate the discovery of novel liver failure treatments:
"Aiming to speed up and facilitate the clinical development of liver failure treatments, Taconic launches the first commercially available diet-induced NASH rodent model...there is an increased demand for preconditioned models, since some of the available models require up to 26 weeks to become ready for study, causing time delays for drug discovery."
Read the complete article at: outsourcing-pharma.com
"Aiming to speed up and facilitate the clinical development of liver failure treatments, Taconic launches the first commercially available diet-induced NASH rodent model...there is an increased demand for preconditioned models, since some of the available models require up to 26 weeks to become ready for study, causing time delays for drug discovery."